A new study in the European Heart Journal shows gene editing may offer a one-time fix for inherited high cholesterol. By targeting liver genes like PCSK9, it could help people who don't respond well to daily meds or can't lower their LDL enough. This breakthrough points to long-term prevention of heart disease with just a single treatment.